The Lilly Biotechnology Center in San Diego (Max Bayer for Endpoints News)

Lil­ly ex­ec says de­vel­op­ing new ther­a­pies for lu­pus is 'in scope'

De­spite pri­or set­backs, Lil­ly ex­ec­u­tives said they’re press­ing ahead with new re­search in lu­pus at a time when oth­er com­pa­nies are tak­ing to cell ther­a­py …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.